Meningitis in Korean patients with systemic lupus erythematosus: Analysis of demographics, clinical features and outcomes; Experience from affiliated hospitals of the Catholic University of Korea

Lupus

Volumn 20, Issue 5, 2011, Pages 531-536

  Kim, J M ^a   Kim, K J ^b   Yoon, H S ^a   Kwok, S K ^a   Ju, J H ^a   Park, K S ^a   Cho, C S ^b   Kim, H Y ^a   Park, S H ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

central nervous system; infection; meningitis; neuropsychiatric lupus; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HYDROXYCHLOROQUINE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTICLE; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CLINICAL FEATURE; CRYPTOCOCCUS NEOFORMANS; DEMOGRAPHY; FEMALE; FUNGUS ISOLATION; HUMAN; HYPOGLYCEMIA; KOREA; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MEDICAL RECORD REVIEW; MENINGITIS; MENTAL DISEASE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENINGITIS; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79955664280     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310384495     Document Type: Article

References (22)

1. Tsao CH, Chen CY, Ou LS, Huang JL. Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 1214-1218
2. Wu KC, Yao TC, Yeh KW, Huang JL. Osteomyelitis in patients with systemic lupus erythematosus. J Rheumatol. 2004 ; 31: 1340-1343
3. Juarez M, Misischia R, Alarcon GS. Infections in systemic connective tissue diseases: Systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin North Am. 2003 ; 29: 163-184 (Pubitemid 36298109)
4. Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996 ; 25: 318-336 (Pubitemid 26123844)
5. Compton MM, Caron LA, Cidlowski JA. Glucocorticoid action on the immune system. J Steroid Biochem. 1987 ; 27: 201-208 (Pubitemid 18059224)
6. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992 ; 19: 1559-1565
7. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol. 1991 ; 18: 1180-1184
8. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus. 2001 ; 10: 505-510 (Pubitemid 32675052)
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
10. Nived O, Sturfelt G, Liang MH, De Pablo P. The ACR nomenclature for CNS lupus revisited. Lupus. 2003 ; 12: 872-876 (Pubitemid 38082080)
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
12. Hung JJ, Ou LS, Lee WI, Huang JL. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol. 2005 ; 32: 40-43
13. Yang CD, Wang XD, Ye S, et al. Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus. Clin Rheumatol. 2007 ; 26: 895-901 (Pubitemid 46951285)
14. Baizabal-Carvallo JF, Delgadillo-Marquez G, Estanol B, Garcia-Ramos G. Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus. Eur Neurol. 2009 ; 61: 143-148
15. Gottfredsson M, Perfect JR. Fungal meningitis. Semin Neurol. 2000 ; 20: 307-322
16. Diamond RD, Allison AC. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun. 1976 ; 14: 716-720
17. Miller GP, Kohl S. Antibody-dependent leukocyte killing of Cryptococcus neoformans. J Immunol. 1983 ; 131: 1455-1459 (Pubitemid 13048906)
18. Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001 ; 60: 1141-1144 (Pubitemid 33096079)
19. Bermas BL, Petri M, Goldman D, et al. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol. 1994 ; 14: 169-177 (Pubitemid 24182177)
20. Tam LS, Li EK, Wong SM, Szeto CC. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol. 2002 ; 31: 296-300 (Pubitemid 35252543)
21. Gladman DD, Hussain F, Ibanez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002 ; 11: 234-239 (Pubitemid 34506728)
22. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 1475-1482 (Pubitemid 26314980)